Patient Registries: An Underused Resource for Medicines Evaluation-Reference-Cited by-同舟云学术

Patient Registries: An Underused Resource for Medicines Evaluation

Published:2019-07-13 Issue:11 Volume:42 Page:1343-1351
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

McGettigan Patricia^ORCID,Alonso Olmo Carla,Plueschke Kelly,Castillon Mireia,Nogueras Zondag Daniel,Bahri Priya,Kurz Xavier,Mol Peter G. M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-019-00848-9.pdf

Reference36 articles.

1. Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence—what is it and what can it tell us? N Engl J Med. 2016;375(23):2293–7.

2. Makady A, de Boer A, Hillege H, Klungel O, Goettsch W, on behalf of GetReal Work Package 1. What is real-world data? a review of definitions based on literature and stakeholder interviews. Value Health J Int Soc Pharmacoecon Outcomes Res. 2017;20(7):858–65.

3. Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User’s Guide. Agency for Healthcare Research and Quality. 2007. https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-guide_research.pdf . Accessed 30 June 2019.

4. Zaletel, M, Kralj, M, Magajne, M, Doupi, P. Methodological Guidelines and Recommendations for Efficient and Rational Governance of Patient Registries. PARENT. Vol. 25. 2015. https://ec.europa.eu/health/sites/health/files/ehealth/docs/patient_registries_guidelines_en.pdf . Accessed 30 June 2019.

5. European Medicines Agency. Patient Registries. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000658.jsp&mid=WC0b01ac0580961211 . Accessed 30 June 2019.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Framework for Multistakeholder Patient Registries in the Field of Rare Diseases;Neurology;2024-09-24

2. A rare partnership: patient community and industry collaboration to shape the impact of real-world evidence on the rare disease ecosystem;Orphanet Journal of Rare Diseases;2024-07-10

3. Real‐World Evidence to Support EU Regulatory Decision Making—Results From a Pilot of Regulatory Use Cases;Clinical Pharmacology & Therapeutics;2024-07-04

4. Creation of a Limb Loss and Preservation Registry for Improving the Quality of Patient Care in the United States;Archives of Rehabilitation Research and Clinical Translation;2024-07

5. Catching up but still miles behind—a patient registry for otoferlin;Experimental & Molecular Medicine;2024-06-03